Mark W. Salyer
Mr. Salyer joined Amarin in September 2017 with extensive experience in sales and marketing for global pharmaceutical companies. Mr. Salyer has grown start-up business units to over $1B in yearly revenue, including Teva’s respiratory products unit. Prior to Teva, Mr. Salyer led U.S. commercial operations and the global respiratory marketing group at Altana Pharma AG. Mr. Salyer also worked at GlaxoSmithKline for 17 years, where he held a variety of jobs with increasing responsibility culminating in his last position of VP, global commercial strategy for the respiratory division.
sales and marketing for global pharmaceutical companies